KOCHI: Artificial blood, designed to save lives during wars and natural disasters, is expected to reach the market by 2030. Considering the rising need in such situations, countries like the US, Japan, and the UK have intensified research. The artificial blood developed in Japan has a purple colour.

Like natural blood, artificial blood also contains red blood cells and haemoglobin. Its main role is to carry oxygen throughout the body and remove waste. However, artificial blood is primarily designed as an oxygen carrier.

Japan has been testing artificial blood on animals since 2019 and on humans since 2020. It is aiming for commercial release by 2030. The main component is purified haemoglobin taken from humans or animals, which is then developed into red blood cells to make it function l

See Full Page